01940nas a2200337 4500000000100000008004100001260001300042653002100055653002600076653003000102653002000132653003000152653002200182653001100204653002300215653002500238653000900263653001600272653002500288653001500313653001100328653001400339100001100353700001400364700001500378245004800393300000900441490000700450520113100457022001401588 1998 d c1998 Feb10aAnterior Chamber10aAnti-Bacterial Agents10aDrug Therapy, Combination10aEye Enucleation10aEye Infections, Bacterial10aFollow-Up Studies10aHumans10aLeprostatic Agents10aLeprosy, lepromatous10aMale10aMiddle Aged10aMycobacterium leprae10aRecurrence10aSclera10aScleritis1 aPoon A1 aMacLean H1 aMcKelvie P00aRecurrent scleritis in lepromatous leprosy. a51-50 v263 a

BACKGROUND: Recurrent immune-mediated scleritis after adequate treatment of leprosy is not well documented in the literature. We describe an Australian resident with unilateral intra-ocular lepromatous leprosy who had persistent non-infectious scleritis.

METHODS: A man of Anglo-Indian ancestry initially presented with lepromatous leprosy and unilateral ocular involvement. The affected eye had an interstitial keratitis and a granulomatous anterior uveitis that responded to antileprotics and anti-inflammatory agents. Despite systemic cure with triple antileprotic therapy, he developed recurrent scleritis that required multiple scleral patch grafts for scleral thinning and, subsequently, an enucleation. Histology failed to demonstrate persistent infection, rather a chronic non-granulomatous scleritis, which was probably immune mediated.

RESULTS/CONCLUSIONS: This case demonstrates an ocular complication of leprosy that is infrequently reported. Patients with ocular involvement by leprosy are at risk of developing recurrent scleritis despite systemic cure with antileprotics.

 a0814-9763